CSPG4 and astrocytic tumor: In astrocytic tumors, the Kaplan–Meier survival analysis revealed a shorter median survival time for NG2/CSPG4-positive cases (n = 4, 16 months) compared to NG2/CSPG4-negative ones (n = 20, 19 months), but the difference was not statistically significant (data not shown).